<DOC>
	<DOCNO>NCT01484327</DOCNO>
	<brief_summary>Beta-blockers administer patient heart failure stag II IV NYHA . It also administer patient stage I myocardial infarction . The low ejection fraction , especially myocardial infarction strong indication beta-blockers , many study indicate administration drug substantially reduce cardiovascular mortality . Beta-blockers reduce mortality hospitalization improve operational phase category patient heart failure . Since beta-blockers , carvedilol , metoprolol , recently visoprololi nevimpololi show benefit thus , administer . The clinical study Carvedia aim observe record action beta-blocker carvedilol cardiac function patient heart failure reduce leave ventricular ejection fraction acute myocardial infarction .</brief_summary>
	<brief_title>Carvedilol Vascular Efficacy Trial</brief_title>
	<detailed_description>The relationship stroke volume , extrude left ventricle give measure restrictive leave ventricular function . Any patient know cardiovascular disease undergo assessment leave ventricular function measure ejection fraction . Several study show ejection fraction ( LVEF ) , measure heart 's ability eject blood aorta exceed 40 % ( natural price ^ 50 % ) increase dramatically post-infarction mortality . The ejection fraction reliable predictor , measure ultrasonography . The reduced ejection fraction associate increase risk life-threatening arrhythmia , heart failure death . The low ejection fraction , especially myocardial infarction strong indication beta-blockers , many study indicate administration drug substantially reduce cardiovascular mortality .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Carvedilol</mesh_term>
	<criteria>1 . Patients visit outpatient clinic . 2 . Male female patient 18 year 3 . Patients mild heart failure history symptom accord instruction European Society Cardiology ( ESC ) 4 . Patients enter study LVEF &lt; 40 % echocardiography 5 . Patients new diagnosis heart failure 6 . Patients leave ventricular ejection fraction acute myocardial infarction &lt; 40 % 7 . Patients treat hospital previous month inclusion study 8 . Patients sign consent form record process personal data . 9 . Patients willing comply requirement study 10 . Patients treat carvedilol least month inclusion 1 . Patients 18 year 2 . Patients unstable chronic heart failure 3 . Patients unstable hemodynamic profile 4 . Patients heart valve disease 5 . Patients hypertrophic cardiomyopathy 6 . Patients unstable angina active myocarditis 7 . Patients contraindication treatment betaadrenergic receptor 8 . Patients consent record process personal data . 9 . Women pregnant breastfeed 10 . Patients treat hospital preceding month inclusion study 11 . Patients treat carvedilol less one month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Heart Failure</keyword>
	<keyword>Acute Myocardial Infarction</keyword>
	<keyword>LVEF</keyword>
</DOC>